Evaxion A (EVAX) Interest & Investment Income (2020 - 2026)
Evaxion A (EVAX) posted Interest & Investment Income of $305000.0 for Q1 2026, down 51.28% quarter-over-quarter from $626000.0 in Q4 2025, and down 87.77% year-on-year from $2.5 million in Q1 2025.
Evaxion A (EVAX) Interest & Investment Income (2020 - 2026) Analysis & Trends
Evaxion A (EVAX) has reported Interest & Investment Income for 7 consecutive years, with $305000.0 the latest figure, recorded in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $305000.0, down 87.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (up 23.47% YoY), and the FY2025 annual result was $6.4 million, down 2.23% from the prior year.
- Interest & Investment Income was $305000.0 for Q1 2026 at Evaxion A, down from $626000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $5.6 million in Q1 2024 and troughed at $47000.0 in Q2 2023.
- Average Interest & Investment Income over 5 years is $997294.1, with a median of $546000.0 recorded in 2025.
- Year-over-year, Interest & Investment Income soared 4563.64% in 2022 and tumbled 96.95% in 2023.
- Over 5 years, Interest & Investment Income stood at $70000.0 in 2022, then soared by 698.57% to $559000.0 in 2023, then advanced by 3.4% to $578000.0 in 2024, then grew by 8.3% to $626000.0 in 2025, then slumped by 51.28% to $305000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $305000.0 in Q1 2026, $626000.0 in Q4 2025, and $2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | 44.00 Mn |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | - |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 27.66 Mn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 114.80 Mn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | - |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | - |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 44.00 Mn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 26.60 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | 19.51 Mn |
| 10 | Evaxion A | 1.33 Bn | 1.33 Bn | - | 305,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305,000.00 |
| Dec 31, 2025 | 626,000.00 |
| Sep 30, 2025 | 2.69 Mn |
| Jun 30, 2025 | 546,000.00 |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 578,000.00 |
| Sep 30, 2024 | 84,000.00 |
| Jun 30, 2024 | 220,000.00 |
| Mar 31, 2024 | 5.62 Mn |
| Dec 31, 2023 | 559,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 47,000.00 |
| Mar 31, 2023 | 285,000.00 |
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 703,000.00 |
| Jun 30, 2022 | 1.54 Mn |
| Mar 31, 2022 | 519,000.00 |
| Dec 31, 2021 | 746,000.00 |
| Sep 30, 2021 | 288,000.00 |
| Jun 30, 2021 | 33,000.00 |